The last 10 years have seen a major paradigm shift in the management of thyroid cancer,
with greater reliance on serum thyroglobulin and neck ultrasonography, and less emphasis …

Opinion statement The incidence of epithelial derived thyroid cancer (papillary thyroid
cancer [PTC] and follicular thyroid cancer, known collectively as differentiated thyroid …

(1). With appropriate initial treatment, the majority of those patients can expect to achieve
good disease-specific outcomes. However, up to 30% of patients (2) will suffer persistent …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Context: The current use of life-long follow-up in patients with papillary thyroid cancer (PTC)
is based largely on the study of individuals diagnosed and treated in the latter half of the …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Low-risk papillary cancers, which represent the vast majority of thyroid cancers diagnosed
today, do not require aggressive treatment or follow-up. Initial treatment consists of a total …

Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …

Clinical members of the American Thyroid Association were surveyed in regard to their
diagnostic assessment, treatment, and long term assessment of differentiated papillary …